What If I Get Pregnant While on GLP-1 Medication?
Questions to discuss with your OB-GYN and prescribing provider if pregnancy occurs during GLP-1 treatment, including current medication and prenatal care.
More on What If Questions
What to Do Right Now
Step 1: Stop the Medication
Do not take your next dose. There is no need to "taper off" -- simply stop taking the medication immediately.
Step 2: Contact Your OB-GYN
Tell your OB-GYN which medication you have been taking and discuss your prenatal care with them.
Step 3: Notify Your GLP-1 Provider
Let your prescribing provider know about the pregnancy so they can update your medical records and discontinue refills.
Step 4: Start Prenatal Vitamins
Begin taking a prenatal vitamin with folic acid immediately if you are not already taking one.
Moving Forward
Focus on standard prenatal care: proper nutrition (especially important if your appetite was reduced on GLP-1 therapy), prenatal vitamins, regular OB appointments, and recommended screenings.
Frequently Asked Questions
Will my OB-GYN need to do additional monitoring?
Likely yes. Your OB-GYN may recommend additional ultrasounds and fetal monitoring, especially during the first trimester, to ensure normal development. Be sure to inform your OB-GYN about the specific medication, dosage, and dates of your last injection.
After Your Pregnancy Journey
When you are ready to resume weight management, our team is here to help.
Explore Treatment OptionsMedical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).